American Century Companies Inc. lowered its stake in shares of Waters Co. (NYSE:WAT) by 92.5% in the second quarter, Holdings Channel reports. The firm owned 15,467 shares of the medical instruments supplier’s stock after selling 191,834 shares during the period. American Century Companies Inc.’s holdings in Waters were worth $2,994,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in WAT. Knowledge Leaders Capital LLC boosted its stake in shares of Waters by 1.0% in the 2nd quarter. Knowledge Leaders Capital LLC now owns 26,727 shares of the medical instruments supplier’s stock worth $5,174,000 after buying an additional 277 shares during the last quarter. IFM Investors Pty Ltd boosted its stake in shares of Waters by 12.4% in the 1st quarter. IFM Investors Pty Ltd now owns 2,530 shares of the medical instruments supplier’s stock worth $503,000 after buying an additional 280 shares during the last quarter. MainStreet Investment Advisors LLC boosted its stake in shares of Waters by 6.9% in the 2nd quarter. MainStreet Investment Advisors LLC now owns 4,602 shares of the medical instruments supplier’s stock worth $891,000 after buying an additional 298 shares during the last quarter. Aviva PLC boosted its stake in shares of Waters by 0.8% in the 2nd quarter. Aviva PLC now owns 38,965 shares of the medical instruments supplier’s stock worth $7,543,000 after buying an additional 303 shares during the last quarter. Finally, Armstrong Henry H Associates Inc. boosted its stake in shares of Waters by 2.2% in the 2nd quarter. Armstrong Henry H Associates Inc. now owns 14,319 shares of the medical instruments supplier’s stock worth $2,772,000 after buying an additional 310 shares during the last quarter. Institutional investors and hedge funds own 98.85% of the company’s stock.

WAT has been the topic of several research analyst reports. Zacks Investment Research upgraded Waters from a “sell” rating to a “hold” rating in a research note on Thursday, August 23rd. Morgan Stanley dropped their price objective on Waters from $205.00 to $204.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 25th. Janney Montgomery Scott downgraded Waters from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $230.00 to $211.00 in a research note on Tuesday, July 17th. ValuEngine cut shares of Waters from a “buy” rating to a “hold” rating in a report on Wednesday, May 16th. Finally, Robert W. Baird boosted their target price on shares of Waters from $201.00 to $212.00 and gave the company an “outperform” rating in a report on Wednesday, July 25th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $206.27.

In other news, SVP Elizabeth B. Rae sold 4,000 shares of the company’s stock in a transaction on Monday, August 27th. The shares were sold at an average price of $190.62, for a total value of $762,480.00. Following the transaction, the senior vice president now owns 9,443 shares of the company’s stock, valued at $1,800,024.66. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.98% of the company’s stock.

Shares of WAT stock opened at $192.49 on Friday. The company has a current ratio of 6.58, a quick ratio of 5.95 and a debt-to-equity ratio of 0.58. Waters Co. has a 1 year low of $177.58 and a 1 year high of $220.20. The firm has a market cap of $14.78 billion, a price-to-earnings ratio of 25.70, a price-to-earnings-growth ratio of 2.35 and a beta of 0.96.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, July 24th. The medical instruments supplier reported $1.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.03. Waters had a net margin of 2.12% and a return on equity of 27.85%. The business had revenue of $596.20 million for the quarter, compared to analysts’ expectations of $598.73 million. During the same quarter in the previous year, the firm posted $1.76 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. sell-side analysts expect that Waters Co. will post 8.11 EPS for the current fiscal year.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Story: How to Invest in Growth Stocks

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.